Laura Rutter
Advertisement
Laura Rutter is a SM manager, analytical services at GlaxoSmithKline
Articles by Laura Rutter
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Approves Cosentyx as First Anti-IL-17 Biologic for Polymyalgia Rheumatica
2
One Injection a Month: Efimosfermin Takes Aim at Cirrhosis in MASH
3
The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
4
Marrow Therapeutics Raises $173 Million for In Vivo Blood Therapies
5

